Skip to main content
. 2012 Nov 10;15(1):159–171. doi: 10.1208/s12248-012-9420-z

Fig. 5.

Fig. 5

Hands-on example 2, FP module, simulation of a PK trial when 500 mcg FP are administered to 35 subjects per formulation group (formulations A and B differ in their dissolution rate constants; B dissolves 3-fold faster), and plasma samples are obtained at 0.17, 0.33, 0.5, 1, 1.5, 2, 3, 4, 6, 8, 10, 12, 16, 20, and 24 h after administration